MERIDIAN
M&AHealthcareSIGNED

Trilantic North America Sells SOFIE Biosciences to GE HealthCare for $945 Million

Photo via Pexels
Value
$945M
Acquirer
GE HealthCare
Target
SOFIE Biosciences

Trilantic North America has sold its portfolio company SOFIE Biosciences to GE HealthCare for $945 million. SOFIE Biosciences operates a US network of contract manufacturing sites for PET radiopharmaceuticals.

Read the original at PE Hub →2026-10-05North America
The Meridian Weekly

The week's largest deals and the Iberian ones, every Monday. Free.

MORE DEALS ON MERIDIAN ->